Introduction and Pathophysiology of Haemostasis
Haemostasis is the precise physiological process the body uses to stop bleeding after vascular injury while keeping blood fluid within the normal vascular channels. This complex mechanism unfolds in three sequential phases: primary haemostasis, secondary haemostasis, and fibrinolysis.
- Primary Haemostasis: Vasoconstriction occurs immediately to reduce blood flow, followed by platelet adhesion, activation, and aggregation at the site of injury to form a loose platelet plug.
- Secondary Haemostasis: The coagulation cascade is activated through the intrinsic and extrinsic pathways, converging at factor X to convert soluble fibrinogen into insoluble fibrin strands that stabilize the platelet plug.
- Fibrinolysis: Once tissue repair begins, the plasminogen system breaks down the fibrin meshwork to restore normal blood flow.
A common misconception in clinical practice is that platelets alone cause clotting; in reality, primary and secondary haemostasis rely on each other to create a stable, permanent thrombus.
Classification and Etiology of Bleeding Disorders
Bleeding disorders arise when any component of the haemostatic mechanism fails, leading to either prolonged or spontaneous hemorrhage. Clinicians broadly divide these conditions into two main categories based on their origin:
- Inherited Bleeding Disorders: Genetic mutations passed down through families, usually manifesting early in childhood. Examples include haemophilia A and B, and von Willebrand disease.
- Acquired Bleeding Disorders: Conditions that develop later in life secondary to systemic illnesses, nutritional deficits, or medication use. Common examples include disseminated intravascular coagulation (DIC), vitamin K deficiency, and liver disease.
A defect in primary haemostasis typically presents as mucocutaneous bleeding, such as epistaxis, gum bleeding, and heavy menstrual periods. Conversely, defects in secondary haemostasis generally manifest as deep tissue bleeding, including joint effusions and intramuscular hematomas.
Common Inherited Bleeding Disorders
Inherited bleeding disorders are lifelong conditions requiring careful genetic counseling and management strategies.
- Haemophilia A: An X-linked recessive deficiency of clotting factor VIII. It predominantly affects males, while females serve as asymptomatic carriers.
- Haemophilia B: Also known as Christmas disease, this is an X-linked recessive deficiency of clotting factor IX, presenting with similar clinical severity to haemophilia A.
- Von Willebrand Disease (vWD): The most common inherited bleeding disorder, caused by a deficiency or dysfunction of von Willebrand factor, which impairs both platelet adhesion and factor VIII transport.
Patients with severe haemophilia often experience spontaneous hemarthrosis, which can lead to permanent joint destruction if left untreated with factor replacement therapy.
Acquired Bleeding Disorders: DIC and Vitamin K Deficiency
Acquired bleeding disorders often develop rapidly in hospitalized or acutely ill patients, posing significant clinical emergencies.
- Disseminated Intravascular Coagulation (DIC): A complex systemic condition where widespread microvascular clotting consumes platelets and clotting factors, paradoxically resulting in severe, life-threatening hemorrhage.
- Vitamin K Deficiency: Vitamin K is a fat-soluble vitamin essential for the hepatic synthesis of clotting factors II, VII, IX, and X. Deficiency leads to impaired coagulation and can occur due to malabsorption, prolonged broad-spectrum antibiotic use, or poor dietary intake in neonates.
Treating DIC requires addressing the underlying trigger—such as sepsis or obstetric complications—while simultaneously providing supportive blood products.
Clinical Manifestations and Patient Assessment
Thorough clinical assessment is vital for identifying the presence and severity of a bleeding disorder. Nurses must systematically evaluate the patient's integumentary, musculoskeletal, and gastrointestinal systems.
- Skin and Mucous Membranes: Look for petechiae, purpura, ecchymoses, and persistent oozing from venipuncture sites or gums.
- Musculoskeletal System: Assess for joint swelling, warmth, pain, and restricted range of motion indicative of hemarthrosis.
- Systemic Signs: Monitor for tachycardia, hypotension, pallor, and dizziness, which suggest significant acute blood loss or internal hemorrhage.
A detailed history should explore family bleeding tendencies, medication usage like anticoagulants or NSAIDs, and the timeline of symptom onset after trauma or surgery.
Diagnostic Investigations and Laboratory Tests
Laboratory screening tests help isolate whether a bleeding disorder stems from a platelet defect, a coagulation factor deficiency, or fibrinolytic overactivity.
| Test | What It Measures | Clinical Utility |
|---|
| Platelet Count | Total number of circulating platelets | Identifies thrombocytopenia as a cause of bleeding |
| Prothrombin Time (PT / INR) | Extrinsic and common coagulation pathways | Monitors warfarin therapy and liver function |
| Activated Partial Thromboplastin Time (aPTT) | Intrinsic and common coagulation pathways | Evaluates for haemophilia and heparin therapy |
| Bleeding Time / PFA | Primary haemostatic platelet function | Assesses platelet adhesion and aggregation capabilities |
Specialized assays, such as specific factor activity levels and von Willebrand factor antigen tests, are subsequently ordered to confirm precise diagnoses.
Medical and Pharmacological Management
Medical management focuses on replacing missing clotting components, halting acute bleeding episodes, and preventing future complications.
- Factor Replacement Concentrates: Recombinant or plasma-derived factor VIII or IX infusions are the cornerstone of treating specific haemophilias.
- Desmopressin (DDAVP): A synthetic hormone that stimulates the release of stored von Willebrand factor and factor VIII from endothelial cells, useful in mild haemophilia A and mild vWD.
- Antifibrinolytic Agents: Medications like tranexamic acid stabilize clots by inhibiting the breakdown of fibrin, particularly effective for mucosal bleeding such as dental work or epistaxis.
- Vitamin K Administration: Oral or parenteral vitamin K corrects deficiencies caused by malabsorption, warfarin overdose, or liver dysfunction.
Surgical procedures in these patients require close collaboration with hematology teams to ensure adequate factor coverage prior to incision.
Nursing Care Plan and Patient Education
Comprehensive nursing care involves monitoring for acute complications, implementing safety measures, and empowering patients with lifelong self-management skills.
- Bleeding Precautions: Use soft-bristled toothbrushes, electric razors instead of blades, and minimize invasive venipunctures where possible.
- Pain Management: Avoid non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin, as they inhibit platelet aggregation; use acetaminophen for pain relief instead.
- Joint Protection: During acute hemarthrosis, rest the affected joint, apply ice, and avoid passive range-of-motion exercises until bleeding resolves.
- Lifestyle Guidance: Educate patients to wear medical alert bracelets, avoid contact sports, and recognize early warning signs of internal bleeding such as sudden joint pain or severe headache.